Edinburgh, 18th October, 2018 / Synpromics is pleased to announce positive data presented today by a key partner, uniQure (NASDAQ:QURE), at the European
Edinburgh, 17th October, 2018 / Synpromics is today unveiling its novel drug-regulatable promoter platform at the
Scotland is home to a flourishing life science industry with government supported plans to increase its size to £8bn by 2025.
Edinburgh, UK, 22nd June 2018 / Synpromics, the leader in gene control, is delighted to announce that David Venables, CEO of the Company, has won the ‘Disruptor’ ca
In May, Synpromics attended the ASGCT annual general meeting in Chicago.